Literature DB >> 32555755

PURL: How old is too old for statins?

Bob Marshall1, Nick Bennett1.   

Abstract

When to start, continue, or stop statins in those ages ≥ 75 years has been a quandary. Here's what 2 studies have to say.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32555755      PMCID： PMC7307931     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  5 in total

Review 1.  Primary Prevention With Statins in the Elderly.

Authors:  Martin Bødtker Mortensen; Erling Falk
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

Review 2.  The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future.

Authors:  Neil J Stone; Scott M Grundy
Journal:  Prog Cardiovasc Dis       Date:  2019-11-13       Impact factor: 8.194

Review 3.  Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making.

Authors:  Sonal Singh; Susan Zieman; Alan S Go; Stephen P Fortmann; Nanette K Wenger; Jerome L Fleg; Barbara Radziszewska; Neil J Stone; Sophia Zoungas; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2018-10-02       Impact factor: 5.562

4.  Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.

Authors: 
Journal:  Lancet       Date:  2019-02-02       Impact factor: 202.731

5.  Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.

Authors:  Rafel Ramos; Marc Comas-Cufí; Ruth Martí-Lluch; Elisabeth Balló; Anna Ponjoan; Lia Alves-Cabratosa; Jordi Blanch; Jaume Marrugat; Roberto Elosua; María Grau; Marc Elosua-Bayes; Luis García-Ortiz; Maria Garcia-Gil
Journal:  BMJ       Date:  2018-09-05
  5 in total
  1 in total

1.  Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study.

Authors:  Fung-Chang Sung; Yi-Ting Yeh; Chih-Hsin Muo; Chih-Cheng Hsu; Wen-Chen Tsai; Yueh-Han Hsu
Journal:  Cancers (Basel)       Date:  2022-02-06       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.